EINECS 200-535-1 en es it fr

EINECS 200-535-1 Brand names, EINECS 200-535-1 Analogs

EINECS 200-535-1 Brand Names Mixture

  • No information avaliable

EINECS 200-535-1 Chemical_Formula

C5H14N1O1

EINECS 200-535-1 RX_link

No information avaliable

EINECS 200-535-1 fda sheet

EINECS 200-535-1 msds (material safety sheet)

http://www.jtbaker.com/msds/englishhtml/c4092.htm

EINECS 200-535-1 Synthesis Reference

No information avaliable

EINECS 200-535-1 Molecular Weight

264.166 g/mol

EINECS 200-535-1 Melting Point

113 oC (Boiling point), 244-247 oC MP as chloride salt.

EINECS 200-535-1 H2O Solubility

Soluble

EINECS 200-535-1 State

Liquid

EINECS 200-535-1 LogP

No information avaliable

EINECS 200-535-1 Dosage Forms

No information avaliable

EINECS 200-535-1 Indication

For nutritional supplementation, also for treating dietary shortage or imbalance

EINECS 200-535-1 Pharmacology

This compound is needed for good nerve conduction throughout the CNS (central nervous system) as it is a precursor to acetylcholine (ACh). Choline is also needed for gallbladder regulation, liver function and lecithin (a key lipid) formation. Choline also aids in fat and cholesterol metabolism and prevents excessive fat build up in the liver. Choline has been used to mitigate the effects of Parkinsonism and tardive dyskinesia. Choline deficiencies may result in excessive build-up of fat in the liver, high blood pressure, gastric ulcers, kidney and liver dysfunction and stunted growth.

EINECS 200-535-1 Absorption

No information avaliable

EINECS 200-535-1 side effects and Toxicity

Oral rat LD50: 3400 mg/kg

EINECS 200-535-1 Patient Information

No information avaliable

EINECS 200-535-1 Organisms Affected

Humans and other mammals